Home The Market For DNA-Sequencing-Based Down's Syndrome Tests Could Exceed $6 Billion
 

Keywords :   


The Market For DNA-Sequencing-Based Down's Syndrome Tests Could Exceed $6 Billion

2014-02-28 20:33:02| Biotech - Topix.net

On Wednesday night the New England Journal of Medicine published a study showing that a new, DNA-sequencing based blood test provides a dramatic improvement in accuracy at screening for Down's syndrome and a second, related disease.

Tags: market tests billion exceed

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05M&S website and app hit by technical issue
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05Producers to be paid grid premiums for AngusLink beef scores
18.05This Week in Agribusiness, May 18, 2024
18.05This Week in Agribusiness, May 18, 2024
More »